alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**UN PUBLISHED** 

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 11**  **- 1356** 

RODNEY E. HAYS , Plaintiff

– Appellant ,

v. TOWN OF GAULEY BRIDGE, WEST VIRGINIA, a West Virginia Municipal Corporation; WILLIAM KINCAID, individua lly and in his official capacity as Judge of the Gauley Bridge Municipal Court; SEAN WHIPKEY, individually and in his official capacity as a Town of Gauley Bridge Officer; HEATH WHIPKEY, individually and in his official capacity as a Town of Gauley Bridge Police Officer; CHARLES BURKHAMER, individually and in his official capacity as a Town of Gauley Bridge Police Officer , Defendants

- Appellees

.

Appeal from the United States District Court for the Southern District of West Virgini a , at Charleston

. John T. Copenhaver, Jr. , District Judge. ( 2:09

- cv
- 01272 )

Submitted : July 21, 2011 Decided: July 25, 2011

Before NIEMEYER and GREGORY , Circuit Judges, and HAMILTON, Senior Circuit Judge.

Dismissed by un published per curiam opin ion

.

Rodney E. Hays, Appellant Pro Se. Vaughn Sizemore, BAILEY & WYANT, PLLC, Charleston, West Virginia, for Appellees.2 Unpublished opinions are not binding precedent in this circuit.3 PER CURIAM:
Rodney E. Hays seeks to appeal the district court’s

or der granting partial summary judgment to defendants on his 42

U.S.C. § 1983 (2006) complaint . This court may exercise
jurisdiction only over final orders, 28 U.S.C. § 1291 (200 6 ), and certain interlocutory and collateral orders, 28 U.S.C.

§ 1292 (200 6 ); F ed. R. Civ. P. 54(b); Cohen v. Beneficial Indus.
Loan Corp. , 337 U.S. 541 , 545

- 46 (1949). The order Hays seeks to appeal is neither a final order nor an appealable
interlocutory or collateral order. Accordingly, we dismiss the
appeal for lack of jurisdic tion. We dispense with oral argument
because the facts and legal contentions are adequately presented
in the materials before the court and argument would not aid the
decisional process.

DISMISSED
§ 1100.202 Definitions. For the purposes of this subpart: *Commercially marketed* means selling or offering for sale a tobacco product in the United States to consumers or to any person for the eventual purchase by consumers in the United States.
*Pre-Existing Tobacco Product* means a tobacco product (including those products in test markets) that was commercially marketed in the United States as of February 15, 2007. A Pre-Existing Tobacco Product is not subject to the premarket requirements of section 910 of the Federal Food, Drug, and Cosmetic Act.
*Tobacco product* means any product made or derived from tobacco, or containing nicotine from any source, that is intended for human consumption, including any component, part, or accessory of a tobacco product (except for raw materials other than tobacco used in manufacturing a component, part, or accessory of a tobacco product). The term “tobacco product” does not mean an article that under the Federal Food, Drug, and Cosmetic Act is: a drug (section 201(g)(1)); a device (section 201(h)); a combination product (section 503(g)); or a food (section 201(f)) if such article contains no nicotine or no more than trace amounts of naturally occurring nicotine.
*Tobacco product manufacturer* means any person, including any repacker or relabeler, who— ( 1 ) Manufactures, fabricates, assembles, processes, or labels a tobacco product; or
( 2 ) Imports a finished tobacco product for sale or distribution in the United States.
[81 FR 29102, May 10, 2016, as amended at 88 FR 16552, Mar. 20, 2023]
# EUR-Lex - 31989D0265 - EN

Avis juridique important

*|*

# 31989D0265

**89/265/EEC: Commission Decision of 30 March 1989 approving the plan relating to the examination for residues of substances other than those having a hormonal action submitted by Spain (Only the Spanish text is authentic) **

*
Official Journal L 108 , 19/04/1989 P. 0020 - 0020 *

COMMISSION DECISION of 30 March 1989 approving the plan relating to the examination for residues of substances other than those having a hormonal action submitted by Spain (Only the Spanish text is authentic) (89/265/EEC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community,

Having regard to Council Directive 86/469/EEC of 16 September 1986 concerning examination of animals and fresh meat for the presence of residues (1), and in particular Article 4 thereof,

Whereas, by letter of 21 November 1988, Spain sent the Commission a plan setting out the national measures taken on the examination for residues of the substances referred to in Annex I, Groups A.III and B to Directive 86/469/EEC;

Whereas examination of this plan, as modified, has shown that it conforms to the provisions laid down in Directive 86/469/EEC, and in particular Article 4 (1) thereof;

Whereas the measures provided for in this Decision are in accordance with the opinion of the Standing Veterinary Committee,

HAS ADOPTED THIS DECISION:

Article 1 The plan relating to the examination for residues of the substances referred to in Annex I, Groups A.III and B to Directive 86/469/EEC submitted by Spain is hereby approved.

Article 2 Spain shall adopt the necessary laws, regulations and administrative provisions for the implementation of the plan referred to in Article 1.

Article 3 This Decision is addressed to the Kingdom of Spain.

Done at Brussels, 30 March 1989.

For the Commission

Ray MAC SHARRY

Member of the Commission

(1) OJ No L 275, 26. 9. 1986, p. 36.
IV 

109TH CONGRESS 

2D SESSION H. RES. 879 

Expressing the sense of the House of Representatives that Members of the 

House of Representatives should use alternative fuel vehicles in their 

professional and personal lives. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 20, 2006 

Mr. CLEAVER submitted the following resolution; which was referred to the 

Committee on Energy and Commerce 

RESOLUTION 

Expressing the sense of the House of Representatives that 

Members of the House of Representatives should use 

alternative fuel vehicles in their professional and personal 

lives. 

Whereas the national average price of a gallon of gasoline has 

doubled in the past 3 years; 

Whereas the need to end the Nation’s dependence on foreign 

oil is a vital component of homeland security; 

Whereas the world’s supply of oil is limited and unstable, and 

therefore the need to develop new energy technologies is 

pressing; 

Whereas alternative sources of energy such as ethanol, hydrogen, and electricity have been proven effective and efficient in powering passenger vehicles; 


sroberts on PROD1PC70 with BILLS
2 

•HRES 879 IH 

Whereas there have been several pieces of legislation introduced in the House of Representatives to address the 

growing problem of high gas prices and the need to utilize alternative sources of energy, including the CLEAR 

Act, which would restrict the use of Members’ Representational Allowances for vehicle payments to only alternative fuel vehicles; 

Whereas Members of Congress should follow their own example of setting forth legislation that encourages the use of 

alternatively fueled vehicles; 

Whereas in 2005 the total cost of automobile leases for Members of Congress surpassed $1 million, and a collective 

switch to alternative fuel vehicles, hybrid vehicles, or vehicles powered by bio-fuels could potentially save American taxpayers thousands of dollars annually; and 

Whereas the General Services Administration has already 

purchased over 68,000 alternative fueled vehicles for the 

use of Federal customers, more than any other organization in the United States: Now, therefore, be it 

1 Resolved, That it is the sense of the House of Rep2 resentatives that Members of the House should take the 

3 lead in reducing the Nation’s dependence on foreign oil 

4 and promoting innovative energy technologies by using al5 ternative fuel vehicles in their professional and personal 

6 lives. 

Æ 


sroberts on PROD1PC70 with BILLS
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-START>                             OCT-01-1995
<PERIOD-END>                               SEP-30-1996
<CASH>                                          16,490
<SECURITIES>                                         0<F1>
<RECEIVABLES>                                    8,078<F2>
<ALLOWANCES>                                       470<F2>
<INVENTORY>                                          0<F1>
<CURRENT-ASSETS>                                43,785
<PP&E>                                           3,377
<DEPRECIATION>                                       0<F1>
<TOTAL-ASSETS>                                  48,769<F1>
<CURRENT-LIABILITIES>                            4,668<F1>
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           118
<OTHER-SE>                                      43,773
<TOTAL-LIABILITY-AND-EQUITY>                    48,769
<SALES>                                         19,466
<TOTAL-REVENUES>                                22,307
<CGS>                                            1,912
<TOTAL-COSTS>                                    2,030
<OTHER-EXPENSES>                                16,610
<LOSS-PROVISION>                                     0<F1>
<INTEREST-EXPENSE>                                   0<F1>
<INCOME-PRETAX>                                  5,411
<INCOME-TAX>                                     1,951
<INCOME-CONTINUING>                              3,460
<DISCONTINUED>                                       0<F1>
<EXTRAORDINARY>                                      0<F1>
<CHANGES>                                            0<F1>
<NET-INCOME>                                     3,460
<EPS-PRIMARY>                                     0.27
<EPS-DILUTED>                                     0.27
<FN>
<F1>Amounts inapplicable or not disclosed as a separate line on the Consolidated
Balance Sheets or Consolidated Statement of Operations are reported as 0
herein.
<F2>Notes and Accounts receivable-trade are reported net of allowances for
doubtful accounts in the Consolidated Balance Sheets.
</FN>
        

</TABLE>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          MAR-31-1999
<PERIOD-START>                             APR-01-1998
<PERIOD-END>                               MAR-31-1999
<EXCHANGE-RATE>                                      1
<CASH>                                           7,796
<SECURITIES>                                         0
<RECEIVABLES>                                   18,672
<ALLOWANCES>                                         0
<INVENTORY>                                     23,842
<CURRENT-ASSETS>                                57,278
<PP&E>                                          40,275
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 109,215
<CURRENT-LIABILITIES>                           22,228
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            95
<OTHER-SE>                                      86,100
<TOTAL-LIABILITY-AND-EQUITY>                   109,215
<SALES>                                        143,913
<TOTAL-REVENUES>                               143,913
<CGS>                                          102,876
<TOTAL-COSTS>                                  102,876
<OTHER-EXPENSES>                                46,388
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (232)
<INCOME-PRETAX>                                (5,583)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (5,583)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (5,583)
<EPS-BASIC>                                     (0.59)<F1>
<EPS-DILUTED>                                   (0.59)<F1>
<FN>
<F1>BASIC AND DILUTED EARNINGS PER SHARE SUBSTITUTED FOR PRIMARY AND DILUTED
EARNINGS PER SHARE IN ACCORDANCE WITH STATEMENT OF FINANCIAL ACCOUNTING
STANDARDS NO. 128, "EARNINGS PER SHARE".
</FN>


</TABLE>
| Dated:                May 15,                2008 |                                          |                                       |
|---------------------------------------------------|-----------------------------------------------|--------------------------------------------|
|                                         |                                     |                                  |
|                                              |                                          | /s/ Laurence                Moskowitz |
|                                              | Name:                Laurence Moskowitz       |
|                                              | Title:                Chief Executive Officer |

|         |                                                             |                                          |
|--------------|------------------------------------------------------------------|-----------------------------------------------|
|    |                                                        |                                     |
|         |                                                             | /s/ Kenneth                  G. Torosian |
|         | Name:                  Kenneth G. Torosian                       |
|         | Title:                  Chief Financial                  Officer |

----
# EUR-Lex - 31993L0056 - EN

Avis juridique important

*|*

# 31993L0056

**Commission Directive 93/56/EEC of 29 June 1993 amending Council Directive 82/471/EEC concerning certain products used in animal nutrition **

*
Official Journal L 206 , 18/08/1993 P. 0013 - 0014 Finnish special edition: Chapter 3 Volume 51 P. 0192 Swedish special edition: Chapter 3 Volume 51 P. 0192 *

COMMISSION DIRECTIVE 93/56/EEC of 29 June 1993 amending Council Directive 82/471/EEC concerning certain products used in animal nutrition

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community,

Having regard to Council Directive 82/471/EEC of 30 June 1982 concerning certain products used in animal nutrition (1), as last amended by Commission Directive 93/26/EEC (2), and in particular Article 6 thereof,

Whereas Directive 82/471/EEC provides for the content of the Annexes to be regularly adapted to take account of advances in scientific and technical knowledge;

Whereas the study of the non-protein nitrogenous compound 'ammonium sulfate' and of hydroxyanalogue of methionine and its calcium salt has permitted a beneficial effect in ruminants to be established; whereas authorization for the use of the products in question should therefore be extended to this category of animal;

Whereas the measures provided for in this Directive are in accordance with the Standing Committee on Feedingstuffs,

HAS ADOPTED THIS DIRECTIVE:

Article 1

The Annex to Directive 82/471/EEC is hereby amended as set out in the Annex to this Directive.

Article 2

Member States shall bring into force the laws, regulations or administrative provisions necessary to comply with Article 1 by 30 June 1994 at the latest. They shall immediately inform the Commission thereof.

When Member States adopt these provisions, these shall contain a reference to this Directive or shall be accompanied by such reference at the time of their official publication. The procedure for such reference shall be adopted by Member States.

Article 3

This Directive is addressed to the Member States.

Done at Brussels, 29 June 1993.

For the Commission

René STEICHEN

Member of the Commission

(1) OJ No L 213, 21. 7. 1982, p. 8.

(2) OJ No L 179, 22. 7. 1993, p. 2.

ANNEX

1. In group 2, 'Non-protein nitrogenous compounds', under point 2.2, 'Ammonium salts', the following product is added:

/* Tables: see OJ */

'Hydroxy analogue of methionine' and 4.1.2, 'Calcium salt of hydroxyanalogue of methionine'.
| 1.   | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|----------------|-----------------------------------------------------------------------------------------------------------------------|

| 2.   | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| November 12, 2010 |   | /s/ Evan Myrianthopoulos            |
|-------------------|--------|-------------------------------------|
|              |   | Evan Myrianthopoulos                |
|              |   | Chief Financial Officer             |
|              |   | (Principal Financial Officer)  |
## BILL OF COSTS

TEXAS COURT OF APPEALS, FOURTEENTH DISTRICT, AT HOUSTON

No. 14

- 14

- 00302

- CV

Omega Lout

v.

The Methodist Hospital

(No. 2013

- 55155 IN 333RD DISTR ICT COURT OF HARRIS COUNTY)

TYPE OF FEE CHARGES PAID/DUE STATUS PAID BY

MT FEE

MT FEE

MT F EE

RPT RECORD

CLK RECORD

FILING

STATEWIDE EFILING $10.00

$10.00

$10.00

$136.50

$66.00

$175.00

$20.00 05/08/2015

07/25/2014

06/26/2014

05/28/2014

05/27/2014

04/24/2014

04/24/2014 E

- PAID

E

- PAID

E

- PAID

PAID

PAID

E

- PAID

E

- PAID ANT

ANT

ANT

ANT

ANT

ANT

ANT



### Th e costs incurred on appeal to the Fourteenth Court of Appeals Housto n, Texas

are $427.50

.

Court costs in this cause shall be paid as per the Judgment issued by this Court.

I, CHRISTOPHER A. PRINE, CLERK OF THE FOURTEENTH COURT OF

APPEALS OF THE STATE OF TEXAS, do hereby certify that the above and foregoing is a true and correct copy of the cost bill of THE COURT OF APPEALS FOR THE FOURTEENTH DISTRICT OF TEXAS, showing the charges and payments, in the above numbered and styled cause, as the same appears of record in this office.

### IN TESTIMONY WHEREOF, witness my hand and the Seal of the COURT

OF APPEALS for the Fo urteenth District of Texas, September 3, 2015

.
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 04-6535

LARRY LAMONT BUSH, Plaintiff - Appellant, versus JACK KAVANAUGH, Commissioner; RONALD HUTCHINSON, Warden; SEWALL B. SMITH, Warden; BERNARD FORD, Captain; JAKE SUTTON, Sergeant; R. EULISS, Captain, Defendants - Appellees. Appeal from the United States District Court for the District of Maryland, at Baltimore. Andre M. Davis, District Judge. (CA-02- 3780-AMD) Submitted: September 1, 2004 Decided: September 28, 2004 Before LUTTIG and MOTZ, Circuit Judges, and HAMILTON, Senior Circuit Judge. Affirmed by unpublished per curiam opinion. Larry Lamont Bush, Appellant Pro Se. John Joseph Curran, Jr., Attorney General, Stephanie Judith Lane Weber, OFFICE OF THE ATTORNEY GENERAL OF MARYLAND, Baltimore, Maryland, for Appellees. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).- 2 - PER CURIAM: Larry Lamont Bush appeals the district court’s order denying relief on his 42 U.S.C. § 1983 (2000) complaint. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. See Bush v. Kavanaugh , No. CA-02-3780-AMD (D. Md. Mar. 4, 2004). We grant the motion to submit on the informal briefs and dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
Editorial Note on Part 106
Editorial Note: Nomenclature changes to part 106 appear at 81 FR 49895, July 29, 2016.

§ 106.10 Controls to prevent adulteration by workers. ( a ) A manufacturer shall employ sufficient personnel, qualified by education, training, or experience, to perform all operations, including all required recordkeeping, in the manufacture, processing, packing, and holding of each infant formula and to supervise such operations to ensure that the operations are correctly and fully performed.
( b ) Personnel working directly with infant formula, infant formula raw materials, infant formula packaging, or infant formula equipment or utensil contact surfaces shall practice good personal hygiene to protect the infant formula against contamination. Good personal hygiene includes: ( 1 ) Wearing clean outer garments and, as necessary, protective apparel such as head, face, hand, and arm coverings; and
( 2 ) Washing hands thoroughly in a hand washing facility with soap and running water at a suitable temperature before starting work, after each absence from the work station, and at any other time when the hands may become soiled or contaminated.
( c ) Any person who reports that he or she has, or appears by medical examination or supervisory observation to have, an illness, open lesion (including boils, sores, or infected wounds), or any other source of microbial contamination that creates a reasonable possibility that the safety of an infant formula may be adversely affected, shall be excluded from direct contact with ingredients, containers, closures, in-process materials, equipment, utensils, and infant formula product until the condition is corrected or determined by competent medical personnel not to jeopardize the safety of the infant formula.
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 92 Introduced in House (IH)]

109th CONGRESS
  1st Session
H. RES. 92

   Providing amounts for the expenses of the Committee on Government 
               Reform in the One Hundred Ninth Congress.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 15, 2005

Mr. Tom Davis of Virginia submitted the following resolution; which was 
           referred to the Committee on House Administration

_______________________________________________________________________

                               RESOLUTION

 
   Providing amounts for the expenses of the Committee on Government 
               Reform in the One Hundred Ninth Congress.

    Resolved, 

SECTION 1. AMOUNTS FOR COMMITTEE EXPENSES.

    For the expenses of the Committee on Government Reform (hereafter 
in this resolution referred to as the ``Committee''), including the 
expenses of all staff salaries, there shall be paid, out of the 
applicable accounts of the House of Representatives for committee 
salaries and expenses, not more than $21,349,000 for the One Hundred 
Ninth Congress.

SEC. 2. SESSION LIMITATIONS.

    Of the amount specified in section 1--
            (1) not more than $10,624,500 shall be available for 
        expenses incurred during the period beginning at noon on 
        January 3, 2005, and ending immediately before noon on January 
        3, 2006; and
            (2) not more than $10,724,500 shall be available for 
        expenses incurred during the period beginning at noon on 
        January 3, 2006, and ending immediately before noon on January 
        3, 2007.

SEC. 3. VOUCHERS.

    Payments under this resolution shall be made on vouchers authorized 
by the Committee, signed by the Chairman of the Committee, and approved 
in the manner directed by the Committee on House Administration.

SEC. 4. REGULATIONS.

    Amounts made available under this resolution shall be expended in 
accordance with regulations prescribed by the Committee on House 
Administration.
                                 <all>
```